Michael North's most recent trade in Amedisys Inc. was a trade of 8,277 Common Stock done . Disclosure was reported to the exchange on Feb. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amedisys Inc. | North Michael | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 8,277 | 23,932 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.69 per share. | 16 Feb 2024 | 1,591 | 22,341 (0%) | 0% | 93.7 | 149,061 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 86.43 per share. | 03 Mar 2023 | 5,908 | 4,164 (0%) | 0% | 86.4 | 510,628 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 4,314 | 4,314 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 4,087 | 4,087 | - | - | Restricted Stock Unit (Performance-Based Vesting) | |
| Amedisys Inc. | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,044 | 10,072 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.16 per share. | 20 Feb 2023 | 1,302 | 8,028 (0%) | 0% | 97.2 | 126,502 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,060 | 3,060 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 2,618 | 2,618 | - | - | Restricted Share Units (Performance-Based Vesting) | |
| Amedisys Inc. | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 1,309 | 10,341 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.07 per share. | 17 Feb 2022 | 1,156 | 9,185 (0%) | 0% | 141.1 | 163,077 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 290.02 per share. | 27 Apr 2021 | 1,731 | 8,972 (0%) | 0% | 290.0 | 502,025 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.48 per share. | 20 Feb 2021 | 521 | 10,672 (0%) | 0% | 292.5 | 152,382 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.48 per share. | 20 Feb 2021 | 131 | 11,277 (0%) | 0% | 292.5 | 38,315 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.48 per share. | 20 Feb 2021 | 84 | 11,193 (0%) | 0% | 292.5 | 24,568 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 3,396 | 7,715 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 3,388 | 11,408 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Michael North | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 1,698 | 0 | - | - | Restricted Share Units (Performance-Based Vesting) | |
| Amedisys Inc. | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,600 | 1,600 | - | - | Stock Option (Right to Buy) | |
| Amedisys Inc. | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,271 | 1,271 | - | - | Performance-Based Restricted Shares | |
| Amedisys Inc. | Michael North | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 636 | 8,020 (0%) | 0% | 0 | Common Stock | |
| Amedisys Inc. | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 295.20 per share. | 17 Feb 2021 | 331 | 7,384 (0%) | 0% | 295.2 | 97,711 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 304.47 per share. | 20 Jan 2021 | 774 | 4,319 (0%) | 0% | 304.5 | 235,660 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 304.47 per share. | 20 Jan 2021 | 387 | 5,093 (0%) | 0% | 304.5 | 117,830 | Common Stock |
| Amedisys Inc. | Michael North | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 230.00 per share. | 09 Sep 2020 | 4,069 | 5,417 (0%) | 0% | 230 | 935,870 | Common Stock |